Trump demands that pharma companies lower drug prices
President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries…
Senate committee rejects NIH cuts, boosts budget by $400 million
WASHINGTON — Senators from both parties endorsed a $400 million increase to the budget of the National Institutes…
White House blocks NIH from awarding any research grants
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
NIH is shrinking the number of research grants it funds
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
FDA clears way for Sarepta Therapeutics to use Duchenne drug in some patients
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middle
Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…
Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to market
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
FDA rejects Replimune skin cancer therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sarepta Therapeutics’ Duchenne therapy crisis has a clear lesson
In a matter of a few days last week, Sarepta Therapeutics announced major layoffs, acknowledged the death of…
Sarepta Therapeutics crisis is huge blow to Duchenne families, company
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Patient dies in Sarepta gene therapy trial, adding to safety concerns
A 51-year-old man died last month after receiving an experimental gene therapy developed by Sarepta Therapeutics for an…